This phenomenon supports our finding that high MIF expression is a key factor driving treatment non-response, indicating that MIF upregulation is a broader phenomenon not restricted solely to the tumor cell subpopulation expressing high HMGCR. The gene discussed is HMGCR; the disease is neoplasm.